Compounding Pharmacies: What They Are and Why They Matter

What Compounding Actually Means

When most people think of a pharmacy, they picture a CVS or Walgreens — a retail store that dispenses pre-manufactured medications made in bulk by pharmaceutical companies. A compounding pharmacy is fundamentally different. It is a pharmacy that prepares customized medications from raw ingredients based on a prescriber's specific order.

Compounding has been part of pharmacy practice for centuries — it is, historically, what pharmacies did before mass manufacturing existed. An apothecary would mix ingredients to create a specific formulation for a specific patient. Today, compounding pharmacies fill a gap when commercially available drugs do not meet a patient's needs: a child who needs a liquid version of a drug that only comes as a tablet, a patient allergic to a dye used in a commercial formulation, or — most relevant here — a patient who needs a peptide that is not available as an FDA-approved finished product.

503A vs. 503B: The Two Types

Federal law defines two categories of compounding pharmacies, and understanding the difference is important if you are receiving peptides from one.

503A Pharmacies (Traditional Compounding)

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies. Key characteristics:

• Compound medications based on individual patient prescriptions — one prescription, one patient at a time.
• Regulated primarily by state boards of pharmacy, not the federal FDA.
• Must be licensed in the state where they operate and typically in the state where the patient resides.
• Not required to register with the FDA.
• Cannot produce large batches "in advance" without patient-specific prescriptions (with some limited exceptions).

Most compounding pharmacies in the US operate under 503A. If a telehealth provider writes you a peptide prescription and it is filled by a compounding pharmacy, it is very likely a 503A operation.

503B Outsourcing Facilities

Section 503B was created by the Drug Quality and Security Act of 2013, largely in response to a devastating contamination outbreak at a compounding facility in 2012 that caused a fungal meningitis outbreak, killing 64 people and sickening hundreds more. Key characteristics:

• Can produce compounded drugs in larger batches without patient-specific prescriptions.
• Registered with and inspected by the FDA.
• Must comply with Current Good Manufacturing Practice (cGMP) requirements.
• Must report adverse events to the FDA.
• Subject to more rigorous quality and testing standards.

503B facilities operate more like small pharmaceutical manufacturers. They supply medications to hospitals, clinics, and healthcare providers in bulk. Because of the additional FDA oversight and cGMP requirements, 503B facilities are generally considered to have a higher quality floor than 503A pharmacies.

Why Compounding Pharmacies Matter for Peptides

Many therapeutic peptides that people use are not available as FDA-approved finished drugs. Semaglutide and tirzepatide are notable exceptions — they have full FDA approval and are manufactured by Novo Nordisk and Eli Lilly, respectively. But peptides like BPC-157, sermorelin, CJC-1295, and many others have never gone through the FDA drug approval process.

Compounding pharmacies can legally prepare these peptides when a licensed prescriber determines they are medically necessary for a specific patient. This is the legal pathway through which most people access non-FDA-approved peptides in the United States. The compounding pharmacy obtains pharmaceutical-grade raw materials, compounds the peptide into an injectable form, and dispenses it with a prescription.

Even for FDA-approved peptides like semaglutide, compounding pharmacies have played a role during drug shortages. When commercial supply could not meet demand, compounded versions filled the gap — though this practice has been subject to ongoing legal and regulatory disputes between compounding pharmacies and the brand-name manufacturers.

How to Verify a Compounding Pharmacy Is Legitimate

Not all compounding pharmacies are equal. Here is how to evaluate one:

• Check state licensing. Every legitimate compounding pharmacy must be licensed by its state board of pharmacy. You can verify this through the state board's website. If a pharmacy cannot provide its license number, walk away.
• Ask about accreditation. The Pharmacy Compounding Accreditation Board (PCAB), now administered by the Accreditation Commission for Health Care (ACHC), provides voluntary accreditation for compounding pharmacies. PCAB-accredited pharmacies have undergone third-party quality assessment. While accreditation is not required, it is a strong positive signal.
• 503B registration. If the pharmacy claims to be a 503B outsourcing facility, you can verify this on the FDA's public list of registered outsourcing facilities. If they are not on the list, they are not a 503B.
• Ask about testing. Legitimate compounding pharmacies should be able to tell you about their quality testing procedures — potency testing, sterility testing, endotoxin testing (particularly important for injectables). If they cannot or will not discuss this, that is a red flag.
• Require a prescription. Any compounding pharmacy that offers to sell you a peptide without a valid prescription from a licensed provider is operating outside the law. A legitimate pharmacy will always require a prescription.

Compounding Is Not the Gray Market

It is important to distinguish compounding pharmacies — which are licensed, regulated, and require prescriptions — from gray-market peptide vendors that sell "research chemicals" online without prescriptions. These are completely different channels with completely different quality standards (or lack thereof). We cover the gray market in a later article, but the distinction is fundamental: a compounding pharmacy is a legally regulated entity. A website selling peptides labeled "not for human consumption" is something else entirely.

Next up: how to evaluate the research behind peptide claims — because "a study showed" is one of the most commonly misused phrases in health media.